The Antiviral Activity of Antibodies in Vitro and in Vivo

Overview

Journal Adv Immunol

Specialty Allergy & Immunology

Date 2001 Apr 11

PMID 11293117

Citations 120

Authors

P W Parren

D R Burton

Affiliations

Soon will be listed here.

Citing Articles

Negative Association of Gulf War Illness Symptomatology with Predicted Binding Affinity of Anthrax Vaccine Antigen to Human Leukocyte (HLA) Class II Molecules.

James L, Georgopoulos A Vaccines (Basel). 2025; 13(1).

PMID: 39852867 PMC: 11768865. DOI: 10.3390/vaccines13010088.

Modelling the mechanisms of antibody mixtures in viral infections: the cases of sequential homologous and heterologous dengue infections.

Dugourd-Camus C, Ferreira C, Adimy M J R Soc Interface. 2024; 21(219):20240182.

PMID: 39406340 PMC: 11523103. DOI: 10.1098/rsif.2024.0182.

Experimental Infection Models and Their Usefulness for White Spot Syndrome Virus (WSSV) Research in Shrimp.

Cox N, De Swaef E, Corteel M, Van Den Broeck W, Bossier P, Nauwynck H Viruses. 2024; 16(5).

PMID: 38793694 PMC: 11125927. DOI: 10.3390/v16050813.

Seroprevalence of West Nile Virus in Tampa Bay Florida Patients Admitted to Hospital during 2020-2021 for Respiratory Symptoms.

Underwood E, Vera I, Allen D, Alvior J, ODriscoll M, Silbert S Viruses. 2024; 16(5).

PMID: 38793601 PMC: 11125834. DOI: 10.3390/v16050719.

Development of a SARS-CoV-2 neutralization assay based on a pseudotyped virus using a HIV system.

Liang Z, Tong J, Wu X, Liu S, Wu J, Yu Y MedComm (2020). 2024; 5(4):e517.

PMID: 38525106 PMC: 10959455. DOI: 10.1002/mco2.517.

References

Lefrancois L . Protection against lethal viral infection by neutralizing and nonneutralizing monoclonal antibodies: distinct mechanisms of action in vivo. J Virol. 1984; 51(1):208-14. PMC: 254419. DOI: 10.1128/JVI.51.1.208-214.1984. View

Smith T, Olson N, Cheng R, Liu H, Chase E, Lee W . Structure of human rhinovirus complexed with Fab fragments from a neutralizing antibody. J Virol. 1993; 67(3):1148-58. PMC: 237479. DOI: 10.1128/JVI.67.3.1148-1158.1993. View

Mascola J, Lewis M, Stiegler G, Harris D, Vancott T, Hayes D . Protection of Macaques against pathogenic simian/human immunodeficiency virus 89.6PD by passive transfer of neutralizing antibodies. J Virol. 1999; 73(5):4009-18. PMC: 104180. DOI: 10.1128/JVI.73.5.4009-4018.1999. View

Stoiber H, Clivio A, Dierich M . Role of complement in HIV infection. Annu Rev Immunol. 1997; 15:649-74. DOI: 10.1146/annurev.immunol.15.1.649. View

Prince G, Hemming V, Horswood R, Baron P, Chanock R . Effectiveness of topically administered neutralizing antibodies in experimental immunotherapy of respiratory syncytial virus infection in cotton rats. J Virol. 1987; 61(6):1851-4. PMC: 254189. DOI: 10.1128/JVI.61.6.1851-1854.1987. View

Lafferty K . THE INTERACTION BETWEEN VIRUS AND ANTIBODY. II. MECHANISM OF THE REACTION. Virology. 1963; 21:76-99. DOI: 10.1016/0042-6822(63)90306-4. View

Wright K, Buchmeier M . Antiviral antibodies attenuate T-cell-mediated immunopathology following acute lymphocytic choriomeningitis virus infection. J Virol. 1991; 65(6):3001-6. PMC: 240949. DOI: 10.1128/JVI.65.6.3001-3006.1991. View

Virgin 4th H, Bassel-Duby R, Fields B, Tyler K . Antibody protects against lethal infection with the neurally spreading reovirus type 3 (Dearing). J Virol. 1988; 62(12):4594-604. PMC: 253571. DOI: 10.1128/JVI.62.12.4594-4604.1988. View

Blondel B, Crainic R, Fichot O, Dufraisse G, Candrea A, Diamond D . Mutations conferring resistance to neutralization with monoclonal antibodies in type 1 poliovirus can be located outside or inside the antibody-binding site. J Virol. 1986; 57(1):81-90. PMC: 252701. DOI: 10.1128/JVI.57.1.81-90.1986. View

10.

Moore J, Ho D . HIV-1 neutralization: the consequences of viral adaptation to growth on transformed T cells. AIDS. 1995; 9 Suppl A:S117-36. View

11.

Lamon E, Powell Jr T, Walia A, Lidin B, Srinivas R, Baskin J . Monoclonal IgM antibodies that inhibit primary Moloney murine sarcoma growth. J Natl Cancer Inst. 1987; 78(3):547-56. View

12.

Lederman M, Purvis S, Walter E, Carey J, Medof M . Heightened complement sensitivity of acquired immunodeficiency syndrome lymphocytes related to diminished expression of decay-accelerating factor. Proc Natl Acad Sci U S A. 1989; 86(11):4205-9. PMC: 287419. DOI: 10.1073/pnas.86.11.4205. View

13.

Iorio R, Bratt M . Monoclonal antibodies to newcastle disease virus: delineation of four epitopes on the HN glycoprotein. J Virol. 1983; 48(2):440-50. PMC: 255369. DOI: 10.1128/JVI.48.2.440-450.1983. View

14.

Connor R, Dinces N, Howell A, Pasquali J, Fanger M . Fc receptors for IgG (Fc gamma Rs) on human monocytes and macrophages are not infectivity receptors for human immunodeficiency virus type 1 (HIV-1): studies using bispecific antibodies to target HIV-1 to various myeloid cell surface molecules,.... Proc Natl Acad Sci U S A. 1991; 88(21):9593-7. PMC: 52764. DOI: 10.1073/pnas.88.21.9593. View

15.

Prince A . Challenges for development of hepatitis C virus vaccines. FEMS Microbiol Rev. 1994; 14(3):273-7. DOI: 10.1111/j.1574-6976.1994.tb00099.x. View

16.

Sanner M . Python: a programming language for software integration and development. J Mol Graph Model. 2000; 17(1):57-61. View

17.

Weltzin R, Traina-Dorge V, Soike K, Zhang J, Mack P, Soman G . Intranasal monoclonal IgA antibody to respiratory syncytial virus protects rhesus monkeys against upper and lower respiratory tract infection. J Infect Dis. 1996; 174(2):256-61. DOI: 10.1093/infdis/174.2.256. View

18.

Mascola J, Mathieson B, Zack P, Walker M, Halstead S, Burke D . Summary report: workshop on the potential risks of antibody-dependent enhancement in human HIV vaccine trials. AIDS Res Hum Retroviruses. 1993; 9(12):1175-84. DOI: 10.1089/aid.1993.9.1175. View

19.

Stewart P, Nemerow G . Recent structural solutions for antibody neutralization of viruses. Trends Microbiol. 1997; 5(6):229-33. DOI: 10.1016/S0966-842X(97)01049-4. View

20.

Dimmock N . Neutralization of animal viruses. Curr Top Microbiol Immunol. 1993; 183:1-149. DOI: 10.1007/978-3-642-77849-0. View